AstraZeneca and Daiichi Sankyo’s supplemental Biologics License Application for Enhertu plus pertuzumab has been accepted for Priority Review b ...
Atos has been awarded a €326 million cybersecurity contract by the European Commission under the CLOUD II DPS II MC17 framework, securing its r ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback